CBioto to acquire 37.5% stake in Inverseon - MarketLine Financial Deals

CBioto to acquire 37.5% stake in Inverseon

CBioto to acquire 37.5% stake in Inverseon - MarketLine Financial Deals
CBioto to acquire 37.5% stake in Inverseon
Published Jul 02, 2012
3 pages — Published Jul 02, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

CBio Limited, an Australia-based developer of treatments for anti-inflammatory and autoimmune diseases, has agreed to acquire 143,486,978 shares, representing a 37.5% stake, in Inverseon, Inc.

  
Source:
Document ID
MA115540_120706
Country
Country
Ticker
CBZ=AU
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "CBioto to acquire 37.5% stake in Inverseon" Jul 02, 2012. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/CBioto-to-acquire-37-5-stake-in-Inverseon-2052-83830>
  
APA:
MarketLine Financial Deals. (2012). CBioto to acquire 37.5% stake in Inverseon Jul 02, 2012. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/CBioto-to-acquire-37-5-stake-in-Inverseon-2052-83830>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.